InterCure and Cannasoul Form Strategic Partnership to Advance Cannabis Science and Pharmaceutical Innovation.

Monday, Nov 3, 2025 8:33 am ET1min read
INCR--

InterCure and Cannasoul have signed a strategic investment and collaboration agreement to advance cannabis science and pharmaceutical innovation. The partnership combines InterCure's global pharmaceutical platform with Cannasoul's world-class analytics and scientific innovation. The collaboration comes as the Trump administration explores cannabis rescheduling, potentially unlocking opportunities for international operators like InterCure. InterCure will acquire a 28% ownership position in Cannasoul and has an exclusive path to increase its holdings to 51%.

InterCure and Cannasoul Form Strategic Partnership to Advance Cannabis Science and Pharmaceutical Innovation.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet